CVS Caremark (CVS) Falls 20% On Cautious Comments on PBM From Call
More News related to CVS
- The Brualdi Law Firm, P.C. Announces Class Action Lawsuit Against CVS Caremark Corporation
- Humana and CVS Caremark's MinuteClinic Expand Member Access to Convenient Quality Care
- MinuteClinic Opens First Retail Clinic in Washington, D.C. at CVS/pharmacy Store in Northeast
- Brower Piven Encourages Investors Who Have Losses in Excess of $300,000 From Investment in CVS Caremark Corporation to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsui
- CVS/pharmacy Kicks Off Annual Thanks and Giving(R) Campaign for the St. Jude Children's Research Hospital
More News related to Guidance
- Davenport Downgrades Nokia (NOK) to Neutral
- Sidoti & Co Downgrades Innophos Holdings (IPHS) to Neutral
- Sidoti & Co Downgrades Tyler Technologies (TYL) to Neutral
- China BAK (CBAK) Shares Tumble Amid Q4 Results, Roth Capital Downgrade
- Canaccord Adams Downgrades Micromet (MITI) to Hold
Shares of CVS Caremark (NYSE: CVS) are falling following negative comments from the conference call. Shares are down nearly 20%
CVS said $3.7 billion in contract losses in the quarter. Lost more in PBM business than expected. PBM margin will fall 10% in 2010.
Related Categories
GuidanceHot List
Trader Talk
Stocks Mentioned
-0.07Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
